Genetic Engineering & Biotechnology News

SEP15 2018

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link:

Contents of this Issue


Page 0 of 33

This is Your Brain on DREADDs 1 Bispecific Playgrounds? No, Factory Floors 1 In the mAb Race, Don't Stumble at Characterization 1 Multiplexed Immunoassays: Small Samples, Big Pictures 12 Next-Gen Diabetes Therapy & Drug Delivery $617million 2015 $9.67 billion Source: Allied Market Research (CAGR 41%) 2022 September 15, 2018 The Scoop Exosomes from Cancer Cells Could Predict Immune Response 5 Multiplexing Western Blots: More Data, Less Sample 24 Kinetic Analysis of Peptide Aggregation 20 Immunoaffinity Extraction and Bioactive Lipid Profiling 14

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - SEP15 2018